All Stories

  1. Surveillance of the liver in type 2 diabetes: important but unfeasible?
  2. IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids
  3. Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis
  4. The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease
  5. Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 Patients
  6. Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis
  7. Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease
  8. The quest for the missing links in fatty liver genetics: Deep learning to the rescue!
  9. The human liver lipidome is significantly related to the lipid composition and aggregation susceptibility of low-density lipoprotein (LDL) particles
  10. Higher serum infliximab concentrations during induction predict short-term endoscopic response in patients with inflammatory bowel disease
  11. Heterogeneity of phosphatidylcholine metabolism in non-alcoholic fatty liver disease
  12. Hepatic insulin resistance is the basis of bile acid dysmetabolism in non-alcoholic fatty liver disease
  13. Marked underestimation of liver fat content as measured by magnetic resonance versus histology—a systematic review and meta-analysis
  14. Insulin-inducible THRSP maintains mitochondrial function and regulates sphingolipid metabolism in human adipocytes
  15. Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?
  16. In vitro Effects of Bacterial Exposure on Secretion of Zonulin Family Peptides and Their Detection in Human Tissue Samples
  17. Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease
  18. Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver disease
  19. Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
  20. Overfeeding Saturated Fat Increases LDL (Low-Density Lipoprotein) Aggregation Susceptibility While Overfeeding Unsaturated Fat Decreases Proteoglycan-Binding of Lipoproteins
  21. Parallel Sessions
  22. Assessment of Lifestyle Factors Helps to Identify Liver Fibrosis Due to Non-Alcoholic Fatty Liver Disease in Obesity
  23. The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients
  24. The PNPLA3‐I148M variant increases polyunsaturated triglycerides in human adipose tissue
  25. Case reports of two pedigrees with recessive arrhythmogenic right ventricular cardiomyopathy associated with homozygous Thr335Ala variant in DSG2